Rémy Cointreau SA (OTCMKTS:REMYY - Get Free Report) shares passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $8.22 and traded as low as $6.42. Rémy Cointreau shares last traded at $6.42, with a volume of 44,067 shares trading hands.
Analyst Ratings Changes
Separately, BNP Paribas downgraded Rémy Cointreau from a "strong-buy" rating to a "hold" rating in a report on Tuesday, September 10th.
Get Our Latest Stock Analysis on Rémy Cointreau
Rémy Cointreau Trading Down 2.3 %
The stock's 50-day simple moving average is $7.14 and its two-hundred day simple moving average is $8.20. The company has a debt-to-equity ratio of 0.28, a quick ratio of 0.40 and a current ratio of 2.50.
Rémy Cointreau Company Profile
(
Get Free Report)
Rémy Cointreau SA, together with its subsidiaries, engages in the production, sale, and distribution of liqueurs and spirits. It operates through Rémy Martin, Liqueurs & Spirits, and Partner Brands segments. The company offers cognacs, liqueurs, single malt whiskies, gins, rums, brandies, wines, and champagnes primarily under the Cointreau, Metaxa, St-Rémy, Mount Gay, Bruichladdich, The Botanist, Westland, Le Domaine des Hautes Glaces, Belle de Brillet, Telmont, Port Charlotte, Octomore, Rémy Martin, and LOUIS XIII brands.
Read More
Before you consider Rémy Cointreau, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rémy Cointreau wasn't on the list.
While Rémy Cointreau currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.